Lluís Castells Selected Research

Cytomegalovirus Infections (Inclusion Disease)

7/2005

Combined treatment with pegylated interferon (alpha-2b) and ribavirin in the acute phase of hepatitis C virus recurrence after liver transplantation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lluís Castells Research Topics

Disease

13	Infections 01/2022 - 10/2002
8	Fibrosis (Cirrhosis) 01/2018 - 01/2003
6	COVID-19 01/2022 - 01/2021
6	Liver Diseases (Liver Disease) 01/2018 - 04/2011
6	Hepatitis C 01/2018 - 02/2006
4	Chronic Hepatitis C 01/2018 - 04/2016
3	End Stage Liver Disease 06/2020 - 02/2006
3	Hepatocellular Carcinoma (Hepatoma) 06/2018 - 04/2015
3	Hepatitis B 04/2011 - 10/2002
2	Hepatic Encephalopathy 05/2022 - 01/2003
2	Hepatic Veno-Occlusive Disease (Disease, Hepatic Veno-Occlusive) 01/2022 - 02/2012
2	Bacterial Infections (Bacterial Infection) 03/2021 - 01/2020
2	Peritonitis 03/2021 - 07/2014
2	Hepatitis 01/2020 - 05/2015
2	Liver Cirrhosis (Hepatic Cirrhosis) 01/2014 - 08/2008
1	Mycoses (Diseases, Fungus) 01/2022
1	Drug-Related Side Effects and Adverse Reactions 01/2022
1	Bacteremia 03/2021
1	Acute Liver Failure (Fulminant Hepatic Failure) 01/2020
1	Autoimmune Hepatitis 01/2020
1	Virus Diseases (Viral Diseases) 01/2017
1	Renal Insufficiency (Renal Failure) 10/2014
1	HIV Infections (HIV Infection) 01/2014
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 03/2009
1	Visceral Leishmaniasis (Kala Azar) 12/2008
1	Ascites 08/2008
1	Brain Diseases (Brain Disorder) 08/2008
1	Metabolic Diseases (Metabolic Disease) 08/2008
1	Hyponatremia 08/2008
1	Cytomegalovirus Infections (Inclusion Disease) 07/2005
1	Reinfection 07/2005
1	Liver Failure 10/2002

Drug/Important Bio-Agent (IBA)

7	Antiviral Agents (Antivirals)IBA 01/2018 - 07/2005
5	Immunoglobulin G (IgG)IBA 01/2022 - 01/2014
4	SofosbuvirIBA 01/2018 - 05/2015
4	Ribavirin (Virazole)FDA LinkGeneric 01/2017 - 07/2005
3	AntibodiesIBA 01/2022 - 01/2021
3	daclatasvirIBA 10/2017 - 04/2016
2	Pharmaceutical PreparationsIBA 01/2021 - 01/2018
2	Immunosuppressive Agents (Immunosuppressants)IBA 01/2021 - 01/2018
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2020 - 07/2005
2	InterferonsIBA 01/2017 - 07/2005
2	Cytidine Triphosphate (CTP)IBA 01/2017 - 04/2016
2	Immunoglobulins (Immunoglobulin)IBA 04/2011 - 02/2006
2	DNA (Deoxyribonucleic Acid)IBA 04/2011 - 10/2002
1	TriazolesIBA 01/2022
1	isavuconazoleIBA 01/2022
1	Calcineurin InhibitorsIBA 01/2022
1	TabletsIBA 01/2018
1	velpatasvirIBA 01/2018
1	Proteins (Proteins, Gene)FDA Link 04/2016
1	SimeprevirIBA 04/2016
1	RNA (Ribonucleic Acid)IBA 04/2016
1	Sorafenib (BAY 43-9006)FDA Link 04/2015
1	Third Generation CephalosporinsIBA 07/2014
1	Formaldehyde (Formol)FDA Link 08/2013
1	AntigensIBA 08/2013
1	ParaffinIBA 08/2013
1	hepatitis B hyperimmune globulinIBA 04/2011
1	Hepatitis B Vaccines (Hepatitis B Vaccine)IBA 03/2009
1	Rifaximin (L 105)FDA Link 01/2003
1	lactitolIBA 01/2003
1	Lamivudine (Epivir)FDA Link 10/2002
1	Hepatitis B Surface Antigens (HBsAg)FDA Link 10/2002

Therapy/Procedure

27	Liver Transplantation 05/2022 - 10/2002
9	Transplantation 01/2022 - 01/2014
5	Therapeutics 01/2021 - 10/2002
2	Surgical Portasystemic Shunt (Portosystemic Shunt) 05/2022 - 02/2012
2	Organ Transplantation 01/2021 - 01/2021
2	Kidney Transplantation 06/2018 - 06/2018
2	Aftercare (After-Treatment) 01/2018 - 01/2017
1	Catheters 03/2021
1	Blood Transfusion (Blood Transfusions) 06/2020